Does Cosentyx (secukinumab) change cholesterol or lipids?
Cosentyx is not known as a cholesterol-lowering or cholesterol-raising medicine. Any effects on cholesterol would be indirect and would show up as changes in standard lipid labs (like LDL, HDL, and triglycerides) during treatment rather than as a targeted action on cholesterol metabolism.
In the information available here, there aren’t specific details on Cosentyx causing predictable changes in cholesterol levels.
Why would people look for a cholesterol effect with Cosentyx?
Patients who take Cosentyx often have inflammatory conditions such as plaque psoriasis, psoriatic arthritis, or ankylosing spondylitis. Chronic inflammation can affect cardiovascular risk and lipid profiles. When inflammation improves on treatment, lipid measures and cardiovascular risk markers can change, but that doesn’t mean the drug itself is designed to alter cholesterol.
What should patients monitor if they’re worried about lipids on Cosentyx?
If you’re using Cosentyx and are concerned about cholesterol, the most useful approach is to monitor standard lipid panels through routine care and follow the usual cardiovascular-risk guidance (diet, exercise, smoking status, and cholesterol medicines if indicated). Track labs before starting and then periodically per your clinician’s plan.
If you tell me your condition (psoriasis vs. psoriatic arthritis vs. ankylosing spondylitis), your baseline cholesterol results, and whether you’re on any statins or other lipid drugs, I can help you think through what changes would be expected and what would be worth asking your doctor about.